Evidence map›Paper›PMID 37771602›Full record

ReviewFaculty reviews2023

Recent advances in therapies for primary myelofibrosis.

William Vainchenker, Nasrine Yahmi, Violaine Havelange, Caroline Marty, Isabelle Plo, Stefan N Constantinescu

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Faculty reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 5 countries.

William VainchenkerINSERM, UMR1287, Gustave Roussy, Villejuif, France.
Nasrine YahmiINSERM, UMR1287, Gustave Roussy, Villejuif, France.
Violaine Havelangede Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Caroline MartyINSERM, UMR1287, Gustave Roussy, Villejuif, France.
Isabelle PloINSERM, UMR1287, Gustave Roussy, Villejuif, France.
Stefan N Constantinescude Duve Institute, Université catholique de Louvain, Brussels, Belgium.
Institut Gustave Roussy · FRCliniques Universitaires Saint-Luc · BELudwig Cancer Research · GBUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary myelofibrosis (PMF), polycythemia vera (PV) and essential thrombocythemia (ET) form the classical

Indexed as

myelofibrosisMyeloproliferative neoplasmstherapeutic approaches

Identifiers

PMID37771602
PMCPMC10523375
OpenAlexW4387047327

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.